{"product_id":"global-neurological-biomarkers-market-2023-2027","title":"Global Neurological Biomarkers Market 2023-2027","description":"\u003cp\u003eGlobal Neurological Biomarkers Market 2023-2027\u003cbr\u003e\nThe neurological biomarkers market is forecasted to grow by USD 6917.68 mn during 2022-2027, accelerating at a CAGR of 12.88% during the forecast period. The report on the neurological biomarkers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.\u003c\/p\u003e\n\n\u003cp\u003eThe report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of neurological disorders, increasing clinical trials for neurological disease-specific biomarkers, and increasing initiatives and support from governments and healthcare organizations.\u003c\/p\u003e\n\n\u003cp\u003eTechnavio's neurological biomarkers market is segmented as below:\u003c\/p\u003e\n\n\u003cp\u003eBy IndicationADPDASDMSOthersBy End-userHospitalsClinical diagnostic centersResearch organizations and othersBy GeographyNorth AmericaEuropeAsiaRest of World (ROW)This study identifies the increasing focus on accurate neurological diagnostics as one of the prime reasons driving the neurological biomarkers market growth during the next few years. Also, blood-based biomarkers availability for neurological disorders and evolution of manual miRNA will lead to sizable demand in the market.\u003c\/p\u003e\n\n\u003cp\u003eThe report on the neurological biomarkers market covers the following areas:Neurological biomarkers market sizingNeurological biomarkers market forecastNeurological biomarkers market industry analysisThe robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurological biomarkers market vendors that include Abbott Laboratories, ACROBIOSYSTEMS INC., Advanced Brain Monitoring Inc., Bio Rad Laboratories Inc., bioMerieux SA, Charles River Laboratories International Inc., EATRIS ERIC, Eli Lilly and Co., Enzo Biochem Inc., F. Hoffmann La Roche Ltd., HU Group Holdings Inc., Merck KGaA, Metabolon Inc., Proteome Sciences plc, QIAGEN NV, Quanterix Corp., Quest Diagnostics Inc., Thermo Fisher Scientific Inc., IQVIA Holdings Inc., and PerkinElmer Inc.. Also, the neurological biomarkers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.\u003c\/p\u003e\n\n\u003cp\u003eThe study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.\u003c\/p\u003e \n\n\u003cp\u003eThe publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"August, 2023 \/ 172 Pages \/ MCW16231892","offer_id":47647417532722,"sku":null,"price":3000.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-neurological-biomarkers-market-2023-2027","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}